If your pharmacy just told you that Lynkuet prior authorization is required, here’s the short version: that message is not a final no. Prior authorization (PA) just means your insurer wants your prescriber to confirm in writing that you fit its coverage rules. Some plans keep it simple — a clear diagnosis and you’re in. Others want more: that you’ve tried other drugs first, or that your baseline lab work is on file. Clear the right boxes and your cost can drop to as little as $25 a month on a commercial plan. We pulled the actual Lynkuet coverage rules from six major insurers and pharmacy benefit managers, plus the FDA label itself.
The fastest way to fix a Lynkuet roadblock is to find out which roadblock you hit:
| What the pharmacy or plan said | Your first move |
|---|---|
| “Prior authorization required” | Ask for the exact rejection code and your plan’s written Lynkuet criteria. |
| “Step therapy required” | Ask which drug or drug type you must try first. Then ask your prescriber what’s already in your chart. |
| “Quantity limit” | Confirm your prescription matches the labeled dose: two 60 mg capsules a day. |
| “Not covered” / “non-formulary” | Ask if a medical exception, formulary exception, or appeal is available. |
| “High cost,” but no rejection | You may be uninsured or it’s not on your plan’s list — jump to the cost section below. |
| You don’t have a prescriber yet | You need a clinician first. See the “Who can help” section below. |
Free: Lynkuet PA Readiness Checklist
Five things insurers check and the exact questions to ask your plan and prescriber. No diagnosis, no coverage guarantee.
Get the free checklist →Lynkuet usually requires prior authorization, step therapy, a quantity-limit check, or a medical exception, depending on your plan — because it’s a new, brand-only medication with no generic.Every plan we reviewed uses one of those steps. Prior authorization is not a denial — it’s a documentation step.
Lynkuet (the brand name for elinzanetant, made by Bayer) was approved by the FDA on October 24, 2025, and reached pharmacies in November 2025. It’s a once-daily capsule for moderate-to-severe vasomotor symptoms — the medical name for hot flashes and night sweats — due to menopause. Lynkuet is not a hormone. It works on brain signals that control body temperature, not on estrogen.
| Term | What it means | What to ask |
|---|---|---|
| Prior authorization (PA) | The plan wants clinical documentation before it pays. | “What exactly does my prescriber need to submit?” |
| Step therapy | The plan wants proof you tried other covered drugs first — or a reason you can’t. | “Which drug or drug type do I have to try first?” |
| Quantity limit | The plan caps how many capsules it covers per fill. | “How many capsules are covered per 30 days?” |
| Medical / formulary exception | A request to cover a drug outside the normal rules. | “Can my prescriber send a medical-necessity statement?” |
Across the plans we reviewed, the most common requirements are a diagnosis of moderate-to-severe hot flashes due to menopause, your menopause status, your prior treatment history (or reasons certain treatments don’t fit you), baseline liver labs, and a dose that matches the plan’s quantity limit.The biggest cause of a denial isn’t being ineligible — it’s a packet that’s missing one piece.
Verified , from each plan’s published policy. Educational only — your exact plan, state, and benefit design control coverage. Sources linked at the bottom.
| Plan / PBM (type, eff. date) | Step therapy — what to try first | Baseline liver labs in criteria? | Quantity limit | Approval length |
|---|---|---|---|---|
| CVS Caremark (commercial template) | None listed — a documented moderate-to-severe VMS diagnosis is the core requirement | Not in the public template (FDA label still requires baseline labs) | 60 caps / 25 days (or 180 / 75 days) | 12 months |
| UnitedHealthcare (commercial; eff. 5/15/2026) | Fail, can’t tolerate, or can’t take ONE hormone therapy OR ONE non-hormonal therapy (after a 30-day trial) | Yes — baseline labs to rule out liver disease | Not specified in this policy | 12 months |
| Prime Therapeutics / Accord (commercial; eff. 1/1/2026) | Fail/can’t take ONE hormone therapy AND ONE non-hormonal therapy (or be over 60, or 10+ years past menopause, for the hormone step) | Yes — baseline ALT, AST, ALP, and total + direct bilirubin under 2× ULN | 60 caps / 30 days | 3 months at first, then 12-month renewals |
| Centene / Trillium (commercial, Marketplace & Medicaid; eff. 3/1/2026) | Fail TWO estrogen products first, unless they aren’t safe for you. Illinois Marketplace plans exempt as of 1/1/2026. | Not called out separately (label labs still apply) | Up to 120 mg/day | 12 months |
| Aetna Better Health (Medicaid — IL, MD, FL Kids, PA; eff. 6/12/2026) | Be unable to take THREE preferred drugs (tried and failed, can’t tolerate, or not safe) | Not called out separately (label labs still apply) | 60 caps / 30 days | 12 months |
| Western Health (commercial; eff. 1/1/2026) | Fail/can’t take ONE hormone therapy OR ONE non-hormonal therapy of a different type | Yes — prescriber confirms baseline ALT, AST, and total bilirubin under 2× ULN | Not specified | 6 months, renewed every 6 months |
1. Step therapy is the real variable. CVS Caremark’s bar is low — a clear diagnosis and you’re in. UHC and Western Health want one other drug on your record. Prime is the strictest: one hormone therapy and one non-hormonal therapy. Centene wants two estrogen products; Aetna Medicaid wants three preferred drugs. The same drug can be a quick yes on one plan and a multi-step process on another. The name on your insurance card matters.
2. The approval clock is short — and varies. First-time approvals run from 3 months (Prime) to 6 months (Western Health) to 12 months (CVS, UHC, Centene, Aetna). Put your renewal date in your calendar so coverage doesn’t lapse mid-treatment.
3. Liver labs show up again and again. Several plans fold the FDA label’s baseline liver-lab rule into their approval criteria. Even when a plan doesn’t list it, the label still calls for it. Missing labs are one of the most common reasons a packet stalls.
Know exactly what your doctor needs to send
Hand your clinician’s office this list and ask what they already have and what’s missing.
Email myself the Prescriber Packet Checklist →Lynkuet’s FDA label tells prescribers to run baseline liver blood tests before you start — ALT, AST, ALP, and bilirubin (total and direct) — and not to start the drug if your ALT or AST is at least 2 times the upper limit of normal, or your total bilirubin is at least 2 times the upper limit of normal. The label also calls for a follow-up liver check 3 months after you begin. Several insurers fold these same liver thresholds into their approval rules, so missing labs can stall a PA even when everything else is in order.
“ULN” stands for upper limit of normal — the top of the normal range on a lab test. The move is simple: ask your prescriber whether your baseline liver labs are done and whether they meet the label and your plan’s requirements. If they’re missing, that’s often the whole reason a PA is stuck.
Veozah carries a boxed warning for liver injury (the FDA’s strongest warning) and requires monthly liver tests for the first three months. Lynkuet does not have a boxed warning. In its three main trials, liver-enzyme jumps of 3× the ULN or higher happened in 0.6% of women on Lynkuet versus 0.4% on placebo.
This page won’t tell you whether Lynkuet is safe for you — your licensed clinician decides that. Use these facts to ask sharper questions.
Some Lynkuet policies use step therapy, meaning you must show that hormone therapy, non-hormonal therapy, or specific preferred drugs were tried, failed, weren’t tolerated, or aren’t safe for you. Step therapy is the single biggest difference between an “easy” plan and a “strict” one.
Some plans list estrogen products — estradiol patches and gels, or Premarin — as the drugs to try before Lynkuet. If you’ve already tried one and it didn’t work or caused problems, that history is gold; make sure it’s in your chart. Ask your prescriber whether your records document a real reason hormone therapy isn’t right for you.
Other plans point to non-hormonal drugs sometimes used for hot flashes — certain antidepressants (SSRIs/SNRIs), gabapentin, or clonidine. A few plans, like Prime, may also count being over 60, or being 10+ years past menopause, as meeting part of the step.
Don’t ask your doctor to write that a drug is contraindicated unless it actually is. Inflating your history can backfire, and it isn’t honest. Instead, ask what’s truly on record: a prior failure, real side effects, a drug interaction, a health condition, or another documented clinical reason. A clean, true history is what wins a PA.
Not sure where you land?
Take the free 60-second quiz to see your fastest covered route. No pressure, no signup.
Take the free 60-second quiz →Submitting a strong Lynkuet PA is a five-step workflow. The whole thing hinges on one person — a prescriber who documents it correctly the first time.
You usually don’t chase the form yourself — your prescriber’s office submits it. The form typically comes from your plan or PBM, your prescriber’s ePA portal, CoverMyMeds, or — if your prescription is routed through BlinkRx — BlinkRx can start the request through CoverMyMeds or by fax. Before anyone fills out anything, get the rejection code and the PBM’s name from your pharmacy, because the wrong form can delay approval.
The prescribing clinician’s office is the key player, because insurers need clinical documentation that only a prescriber can provide. No provider can guarantee a Lynkuet approval, but the right one knows how to document medical necessity and submit a clean PA.
Find yourself in one of these three groups — it points you to the right next step:
If you’re on commercial or PPO insurance and need a prescriber, Midi Health is the option we’d check first. Midi is an independent, insurance-accepting telehealth clinic built specifically for perimenopause and menopause. Here’s what we confirmed, claim by claim:
| What Midi says | What it means for you | What we couldn’t verify |
|---|---|---|
| Available in all 50 states; in-network with most PPO plans; visits and prescriptions covered by insurance | If you have a PPO, your visit may cost just your normal copay | Coverage varies by plan and state — confirm yours before booking |
| Clinicians are trained in midlife women’s health and prescribe both hormonal and non-hormonal options | They can talk through your full menu, not just one lane | Whether a given clinician will prescribe Lynkuet specifically — that’s a clinical decision made in your visit |
| 230,000+ women have used Midi for midlife care | A clinic that does menopause care all day | — |
| Not enrolled with Medicaid/Medi-Cal; not covered by Medicare (self-pay only) | If you’re on a government plan, this isn’t your route | — |
Because a PA is won on documentation, the smart move when you book is to ask directly: will the clinician submit the Lynkuet prior authorization for my plan, and will they help with an appeal if it’s denied?
On commercial or PPO insurance and need a menopause clinician?
Check whether Midi is in-network with your plan before you book — no surprises.
Check if Midi accepts my insurance →Affiliate link — see disclosure above. Midi does not bill Medicare or Medicaid.
BlinkRx is Bayer’s partner digital pharmacy for Lynkuet. When Lynkuet is prescribed through BlinkRx, it can start the medical-exception or prior-authorization request through CoverMyMeds or by fax, work out your copay, and apply the lowest available cost — then ship the drug to your door, usually within 3 to 5 days. What BlinkRx can’t do is replace the clinical documentation — your prescriber still supplies the diagnosis, labs, and history.
What BlinkRx handles
What still comes from your prescriber
If your prescription is going through BlinkRx, ask your prescriber or the pharmacy whether the PA has been started and what they still need from your doctor.
Without insurance, Lynkuet’s cash price through BlinkRx is $625 a month. With commercial insurance plus the BlinkRx copay savings card, eligible patients can pay as little as $25 a month after a PA clears. People on Medicare or Medicaid can’t use the copay card — their cost depends on the plan. Bayer’s patient assistance foundation can provide the drug free to those who qualify by income.
| Your coverage | How you get it covered | Realistic out-of-pocket | The catch |
|---|---|---|---|
| Commercial / employer PPO | PA, then fill through BlinkRx so the copay card applies | As little as $25/month after approval | Copay card has terms and limits; not for government plans |
| Medicare (Part D) | PA through your plan; normal Part D cost-sharing | Varies by plan and phase; the 2026 Part D out-of-pocket cap is $2,100 | Cap applies only to covered Part D drugs, not premiums; copay card can’t be used |
| Medicaid | PA, often with step therapy (e.g., try estrogens first) | Low or no copay if approved on your formulary | Copay card not allowed; rules vary a lot by state |
| Uninsured / not covered | Pay cash via BlinkRx, or apply to Bayer’s assistance foundation | $625/month cash; $0 if you qualify for assistance | Assistance is income-based and usually excludes government-plan members |
A Lynkuet denial is usually not final. Get the exact denial reason in writing, request the plan’s criteria, ask your prescriber what was actually submitted, then decide whether the next step is a corrected resubmission, an appeal, a formulary exception, or a quantity-limit override. Don’t stop at the first rejection message. The path forward starts with the denial letter.
| Denial reason | What’s usually missing | Your path | What to ask next |
|---|---|---|---|
| Missing PA | No authorization was submitted or received | Resubmit | “Did the plan actually receive the PA?” |
| Missing documentation | Diagnosis, severity, history, or labs weren’t included | Resubmit with the missing piece | “Which specific criteria weren’t met?” |
| Step therapy | Proof you tried a preferred drug — or a reason you can’t | Resubmit with that history, or request an override | “Which drug or type do I need to try first?” |
| Quantity limit | The dose or capsule count is over the plan’s limit | Quantity-limit override | “What quantity is covered per 30 days?” |
| Non-formulary / excluded | The drug isn’t normally covered | Medical or formulary exception, then appeal | “Can my prescriber request a medical exception?” |
For Medicare drug denials, the plan needs a prescriber’s supporting statement explaining why the drug is medically necessary. For commercial plans, you have the right to an internal appeal, and often an external review by an independent third party if that fails.
“I got a denial for Lynkuet. Please send me the denial letter, the exact criteria you used, the deadline to appeal, how to submit it, and whether this should be an appeal, a formulary exception, a medical exception, or a quantity-limit override.”
Turn a denial into a plan
Pick your denial reason and get the exact next step and what to ask.
Get the free Lynkuet Denial-Fix Checklist →Lynkuet and Veozah are both non-hormonal prescription drugs for moderate-to-severe hot flashes due to menopause, and many plans cover them under the same vasomotor-symptom policy. Several plans require step therapy — trying a hormone therapy or a non-hormonal option first — before either drug. Don’t assume being approved for one means the other is covered; ask your plan for the exact criteria for the drug your prescriber chose.
See the full Veozah vs. Lynkuet comparison → · Take the free 60-second quiz to compare your options →
What we verified ():
What we did not verify (and you should check for your situation):
By The HRT Index editorial team. This article is general information, not medical advice. Talk to your doctor or pharmacist about your situation.
Does Lynkuet always require prior authorization?
No. Lynkuet coverage rules depend on the plan, but most plans reviewed use prior authorization, step therapy, quantity limits, or exception logic. Always get the exact rejection reason from your pharmacy or plan before assuming it’s a final denial.
Is Lynkuet a hormone?
No. Lynkuet (elinzanetant) is a non-hormonal prescription medicine for moderate-to-severe hot flashes due to menopause. It works on brain receptors (NK1 and NK3) that help regulate body temperature, not on estrogen or other hormones.
How long does Lynkuet prior authorization take?
It varies by plan. For Medicare Part D, a plan must decide a standard request within 72 hours and an expedited (urgent) request within 24 hours, once it has the prescriber’s supporting statement. Commercial and Medicaid timing varies — ask your plan for its standard and urgent PA deadlines. The biggest delay is usually missing documentation, not the plan’s clock.
Why isn’t Lynkuet covered by my insurance?
Usually because it’s new and brand-only, it’s not yet on your plan’s formulary, or your plan requires step therapy you haven’t met. Each of those has a next step — a corrected PA, step-therapy documentation, a formulary exception, or an appeal — though not every case ends in coverage.
What labs are needed before starting Lynkuet?
Lynkuet’s label directs prescribers to run baseline liver tests — ALT, AST, ALP, and total and direct bilirubin — before you start, and not to start if ALT or AST is at least 2× the upper limit of normal or total bilirubin is at least 2× the upper limit of normal. A follow-up liver check is recommended at 3 months.
Can I use the Lynkuet $25 copay offer with Medicare or Medicaid?
No. Eligible commercially insured patients may pay as little as $25 a month, but patients enrolled in any government program — including Medicare, Medicaid, TRICARE, VA, and DoD — are not eligible for the copay savings offer.
Can a telehealth provider prescribe Lynkuet?
A licensed clinician can decide whether a prescription is appropriate based on your medical history, labs, and the rules in your state. No telehealth provider can guarantee access. Think of it as a way to discuss FDA-approved menopause options with a qualified clinician who can handle the paperwork.
Can BlinkRx submit the Lynkuet PA for me?
When Lynkuet is prescribed through BlinkRx, Bayer’s partner pharmacy, it can start the prior-authorization or medical-exception request through CoverMyMeds or fax, and apply any copay savings automatically. But your clinician still supplies the clinical documentation, and your plan still makes the coverage decision.
What if the pharmacy says “quantity limit”?
Ask the plan how many capsules are covered per 30 days, then compare it to your prescription. Lynkuet’s labeled dose is two 60 mg capsules once daily, and several plans set a limit like 60 capsules per 25 or 30 days to match that.
Can a Lynkuet denial be appealed?
Yes. Many denials can be appealed or reconsidered, depending on the plan. Start by requesting the denial letter, the exact criteria used, the appeal deadline, and whether the right next step is an appeal, a medical exception, a formulary exception, or a quantity-limit override.
Can The HRT Index tell me whether I qualify?
No. The HRT Index is an independent comparison resource for HRT telehealth providers — not a medical provider or insurance plan. Our checklist can help you spot missing documentation and ask better questions, but your clinician and insurer decide treatment and coverage.
Still not sure which menopause treatment path is right for you?
Take our free 60-second matching quiz. No pressure, no signup wall — just your personalized next step.
Take the free 60-second quiz →We read Lynkuet’s FDA prescribing information, Bayer’s patient and prescriber support materials, and the current prior-authorization policies from six insurers and pharmacy benefit managers. Then we translated that policy language into a checklist and a coverage map you can actually use. Search for “Lynkuet prior authorization” and you mostly get dense insurance PDFs written for coverage staff — not for the woman standing at the pharmacy counter. This page exists to fix that. Our goal isn’t to predict your approval. It’s to make sure your packet is complete beforeyou call your plan, your prescriber, or your pharmacy — so a fixable paperwork problem doesn’t keep you from relief.
All sources accessed and verified . Coverage rules and prices change — we re-check this page monthly.
